| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |